Main Session
Sep
30
QP 40 - Personalized Therapy and Special populations in Head and Neck Cancer
1238 - Genetic Signatures Predicting Toxicity and Overall Survival in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients in RTOG 0522 Treated with Radiation and Cisplatin
Presenter(s)
Joanne Weidhaas, MD, PhD - UCLA Radiation Oncology, Los Angeles, CA